Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-06-03 Sale |
2024-06-05 4:53 pm |
BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director |
2,500 | $30.32 | $75,793 | 9,000 (Indirect Direct) |
View |
| 2024-03-01 Sale |
2024-03-05 4:00 pm |
BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director |
2,500 | $34 | $85,000 | 11,500 (Indirect Direct) |
View |
| 2024-02-15 Sale |
2024-02-20 4:03 pm |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
2,915 | $37.75 | $110,041 | 98,458 (Indirect Direct) |
View |
| 2021-12-28 Purchase |
2024-02-13 4:05 pm |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
3,433 | $12.96 | $44,476 | 5,197 (Indirect Direct) |
View |
| 2021-12-28 Purchase |
2024-02-13 4:00 pm |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
3,433 | $12.96 | $44,476 | 3,433 (Indirect) |
View |
| 2024-01-16 Sale |
2024-01-18 4:10 pm |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
2,915 | $37.97 | $110,683 | 97,940 (Direct) |
View |
| 2023-12-26 Sale |
2023-12-28 4:00 pm |
BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Director |
100,000 | $42.06 | $4,206,000 | 1,100,065 (Indirect Direct) |
View |
| 2023-12-18 Sale |
2023-12-20 4:00 pm |
BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director |
2,000 | $40 | $80,000 | 14,000 (Indirect Direct) |
View |
| 2023-12-15 Sale |
2023-12-19 4:00 pm |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
2,915 | $36.12 | $105,290 | 100,855 (Direct) |
View |
| 2023-12-01 Sale |
2023-12-05 4:00 pm |
BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director |
2,500 | $29.4 | $73,500 | 16,000 (Indirect Direct) |
View |
| 2023-11-17 Sale |
2023-11-20 4:00 pm |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO |
22,685 | $29.1 | $660,059 | 301,575 (Direct) |
View |
| 2023-11-17 Sale |
2023-11-20 4:00 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
51,552 | $29.1 | $1,500,038 | 7,341,089 (Indirect Direct) |
View |
| 2023-11-15 Sale |
2023-11-17 4:09 pm |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
2,915 | $30 | $87,450 | 103,770 (Direct) |
View |
| 2023-09-05 Sale |
2023-09-07 4:00 pm |
BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director |
2,500 | $30 | $75,000 | 18,500 (Indirect Direct) |
View |
| 2023-08-17 Sale |
2023-08-18 4:00 pm |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO |
22,683 | $28.59 | $648,455 | 346,571 (Direct) |
View |
| 2023-08-17 Sale |
2023-08-18 4:00 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
51,552 | $28.59 | $1,473,784 | 7,443,338 (Indirect Direct) |
View |
| 2023-07-18 Sale |
2023-07-19 9:33 pm |
BridgeBio Pharma Inc. | BBIO | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC Viking Global Opportunities Parent GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
1,500,000 | $35 | $52,500,000 | 25,120,991 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-21 Option Award |
2024-06-25 5:39 pm |
N/A 2034-06-20 |
BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director |
26,014 | $0 | 26,014 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-25 5:39 pm |
N/A 2034-06-20 |
BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Director |
26,014 | $0 | 1,126,079 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-25 5:38 pm |
N/A 2034-06-20 |
BridgeBio Pharma Inc. | BBIO | Lo Andrew Director |
26,014 | $0 | 26,014 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-25 5:38 pm |
N/A 2034-06-20 |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director |
26,014 | $0 | 26,014 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-25 5:36 pm |
N/A 2034-06-20 |
BridgeBio Pharma Inc. | BBIO | DANIELS RONALD J Director |
26,014 | $0 | 26,014 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-25 5:36 pm |
N/A 2034-06-20 |
BridgeBio Pharma Inc. | BBIO | Dachille Douglas A. Director |
26,014 | $0 | 26,014 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-25 5:35 pm |
N/A 2034-06-20 |
BridgeBio Pharma Inc. | BBIO | Cook Jennifer E. Director |
26,014 | $0 | 26,014 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-25 5:34 pm |
N/A 2034-06-20 |
BridgeBio Pharma Inc. | BBIO | AGUIAR ERIC Director |
26,014 | $0 | 26,014 (Direct) |
View |
| 2024-05-16 Exercise |
2024-05-17 4:11 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
121,334 | $0 | 7,576,007 (Direct) |
View |
| 2024-05-16 Tax Withholding |
2024-05-17 4:11 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
30,748 | $31.04 | 7,576,007 (Direct) |
View |
| 2024-05-16 Exercise |
2024-05-17 4:09 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO |
55,014 | $0 | 376,112 (Direct) |
View |
| 2024-05-16 Tax Withholding |
2024-05-17 4:09 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO |
13,943 | $31.04 | 376,112 (Direct) |
View |
| 2024-03-12 Option Award |
2024-03-14 4:00 pm |
N/A 2034-03-11 |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
358,728 | $0 | 358,728 (Direct) |
View |
| 2024-03-12 Option Award |
2024-03-14 4:00 pm |
N/A 2034-03-11 |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO |
122,720 | $0 | 122,720 (Direct) |
View |
| 2024-02-16 Exercise |
2024-02-21 4:04 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO |
89,992 | $0 | 282,777 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-21 4:04 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO |
18,919 | $37.21 | 282,777 (Direct) |
View |
| 2024-02-16 Exercise |
2024-02-21 4:04 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director |
3,760 | $0 | 1,230,085 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-21 4:04 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director |
1,509 | $37.21 | 1,230,085 (Direct) |
View |
| 2024-02-16 Exercise |
2024-02-21 4:03 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
204,498 | $0 | 7,293,167 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-21 4:03 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
47,922 | $37.21 | 7,293,167 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-20 4:03 pm |
N/A 2032-06-22 |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
2,915 | $0 | 98,458 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-20 4:03 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
2,915 | $8.45 | 98,458 (Direct) |
View |
Ownership |
2024-02-13 4:05 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
0 | $0 | 5,197 (Direct) |
View |
| 2024-01-16 Exercise |
2024-01-18 4:10 pm |
N/A 2032-06-22 |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
2,915 | $0 | 97,940 (Direct) |
View |
| 2024-01-16 Exercise |
2024-01-18 4:10 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
2,915 | $8.45 | 97,940 (Direct) |
View |
| 2023-12-15 Exercise |
2023-12-19 4:00 pm |
N/A 2032-06-22 |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
2,915 | $0 | 100,855 (Direct) |
View |
| 2023-12-15 Exercise |
2023-12-19 4:00 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
2,915 | $8.45 | 100,855 (Direct) |
View |
| 2023-11-16 Exercise |
2023-11-20 4:00 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO |
89,992 | $0 | 301,575 (Direct) |
View |
| 2023-11-16 Tax Withholding |
2023-11-20 4:00 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO |
22,311 | $28.86 | 301,575 (Direct) |
View |
| 2023-11-16 Exercise |
2023-11-20 4:00 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
204,498 | $0 | 7,341,089 (Direct) |
View |
| 2023-11-16 Tax Withholding |
2023-11-20 4:00 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
50,697 | $28.86 | 7,341,089 (Direct) |
View |
| 2023-11-16 Exercise |
2023-11-20 4:00 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director |
3,760 | $0 | 1,230,756 (Direct) |
View |
| 2023-11-16 Tax Withholding |
2023-11-20 4:00 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director |
1,301 | $28.86 | 1,230,756 (Direct) |
View |
| 2023-11-15 Exercise |
2023-11-17 4:09 pm |
N/A 2032-06-22 |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
2,915 | $0 | 103,770 (Direct) |
View |
| 2023-11-15 Exercise |
2023-11-17 4:09 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
2,915 | $8.45 | 103,770 (Direct) |
View |
| 2023-08-16 Tax Withholding |
2023-08-18 4:00 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director |
1,301 | $29.8 | 1,232,057 (Direct) |
View |
| 2023-08-16 Exercise |
2023-08-18 4:00 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director |
3,760 | $0 | 1,232,057 (Direct) |
View |
| 2023-08-16 Tax Withholding |
2023-08-18 4:00 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO |
22,311 | $29.8 | 346,571 (Direct) |
View |
| 2023-08-16 Exercise |
2023-08-18 4:00 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO |
89,988 | $0 | 346,571 (Direct) |
View |
| 2023-08-16 Tax Withholding |
2023-08-18 4:00 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
50,698 | $29.8 | 7,443,338 (Direct) |
View |
| 2023-08-16 Exercise |
2023-08-18 4:00 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
204,500 | $0 | 7,443,338 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:25 pm |
N/A 2033-06-21 |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
51,501 | $0 | 51,501 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:24 pm |
N/A 2033-06-21 |
BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director |
51,501 | $0 | 51,501 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:23 pm |
N/A 2033-06-21 |
BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director |
51,501 | $0 | 51,501 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:22 pm |
N/A 2033-06-21 |
BridgeBio Pharma Inc. | BBIO | MOMTAZEE JAMES C Director |
51,501 | $0 | 51,501 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:21 pm |
N/A 2033-06-21 |
BridgeBio Pharma Inc. | BBIO | Lo Andrew Director |
51,501 | $0 | 51,501 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:20 pm |
N/A 2033-06-21 |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director |
51,501 | $0 | 51,501 (Direct) |
View |